Table 3.
a. Isolated skull fractures excluded from intracranial lesions. | ||
---|---|---|
| ||
Table 3a. | CT positive | CT negative |
GFAP positive >0.15 ng/ml | 17 | 71 |
GFAP negative ≤0.15 ng/ml | 1 | 63 |
Sensitivity | 94% (71-100) | |
Specificity | 47% (38-56) | |
NPV | 98% (90-100) | |
PPV | 19% (12-29) | |
| ||
b. Isolated skull fractures included with intracranial lesions. | ||
| ||
Table 3b. | CT positive | CT negative |
| ||
GFAP positive>0.15 ng/ml | 20 | 68 |
GFAP negative ≤0.15 ng/ml | 1 | 63 |
Sensitivity | 95% (74-100) | |
Specificity | 48% (39-56) | |
NPV | 98% (90-100) | |
PPV | 22% (15-33) | |
| ||
c. Patients presenting with a GCS 15. | ||
| ||
Table 3c. | CT positive | CT negative |
| ||
GFAP positive >0.15 ng/ml | 14 | 60 |
GFAP negative ≤0.15 ng/ml | 1 | 60 |
Sensitivity | 93% (66-100) | |
Specificity | 50% (41-59) | |
NPV | 98% (90-100) | |
PPV | 19% (11-30) |
CT = computed tomography; GFAP = glial fibrillary acidic protein; NPV = negative predictive value; PPV = positive predictive value